Founded in 1888.
This company was awarded the 'Industry Group Leader' in the Health Care Equipment & Services category of the Dow Jones Sustainability Index (DJSI) every year from 2013-2017. The DJSI is based on an analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, branding, climate change mitigation, supply chain standards and labor practices.
[Source 2017][More on Sustainability Reporting]
This company pleaded guilty to federal charges that it improperly promoted the drug Depakote to elderly dementia patients in nursing homes. It reached an agreement with the Department of Justice to settle the investigation for $1.5 billion in May 2012. The company faces more lawsuits over the drug, which can cause birth defects.
[Source 2012][More on Irresponsible marketing]
This company is named and shamed in IBFAN's 2017 report, 'Breaking the Rules, Stretching the Rules 2017', evidence of violations of the International Code of Marketing of Breastmilk Substitutes, compiled from June 2014 to June 2017. The report covers 792 Code violations from 79 countries and by 28 companies.
[Source 2017][More on Irresponsible Marketing]
This company received a score of 39.3/100 in the Newsweek Green Ranking 2017, which ranks the world's largest publicly traded companies on eight indicators covering energy, greenhouse gases, water, waste, fines and penalties, linking executive pay to sustainability targets, board-level committee oversight of environmental issues and third-party audits. Ranking methodology by Corporate Knights and HIP Investor.
[Source 2017][More on Sustainability Reporting]
Independent testing commissioned by Friends of the Earth in 2015 found potentially harmful nanoparticles in popular baby formulas sold throughout the USA, including products by this company. A growing body of scientific research demonstrates that nanoparticles pose threats to human health, raising concerns about their use in food and many other consumer products.
[Source 2015][More on Product Safety]
In 2013 China fined six companies, including this one, a total of $110 million following an investigation into price fixing and anti-competitive practices by foreign baby formula makers.
[Source 2013][More on Governance]
A 2018 report by Oxfam shows that four pharmaceutical corporations, including this one, systematically hide their profits in overseas tax havens. This activity could deprive developing countries of more than $100 million every year. These corporations deploy massive influencing operations to rig the rules in their favor and give their damaging behavior a veneer of legitimacy. Tax dodging, high prices, and influence peddling by drug companies exacerbate the yawning gap between rich and poor, between men and women, and between advanced economies and developing ones.
[Source 2018][More on Finance]
This company has products rated RED in the Centre for Food Safety's True Food Shopper's Guide (USA). Products on the RED list contain ingredients that come from the most common GE crops (corn, soy, canola, cotton). Companies with products on this list have confirmed that their products may have or are likely to be made with GE ingredients, or have not denied using GE foods when given the opportunity to do so.
[Source 2013][More on Genetic Engineering]
Named one of Multinational Monitor's '10 Worst Corporations' in 2007. [Listed under information due to age of article]
[Source 2007][More on Human Rights]
As You Sow's 2017 report, 'The 100 Most Overpaid CEOs', reveals the 100 most overpaid CEOs from USA's 500 largest public companies (as determined by the S&P 500 list). This company's CEO, Miles D. White came in at number 64 on the list, having been paid US$19,401,704 in 2015. According to the report, "Most CEOs have come to be grossly overpaid, and that overpayment is harmful to the companies, the shareholders, the customers, the other employees, the economy, and society as a whole."
[Source 2017][More on Finance]
In 2010, Abbott Laboratories, B. Braun Medical and Roxane Laboratories agreed to pay $421 million to resolve claims they had reported false and inflated prices for their drugs, which again affected federal health care reimbursements. The grossly inflated average wholesale price (AWP) caused Medicare and Medicaid programs to spend more per patient than was necessary, thereby reducing the amount of funding available for all patients in need. The drug manufacturers did not admit fault. [Listed under Information due to age of court finding]
[Source 2010][More on Governance]
Named one of Multinational Monitor's '10 Worst Corporations' in 2006. [Listed under information due to age of article]
[Source 2006][More on Politics]
This company has sustainability claims on its website.
[Source 2014][More on Sustainability Reporting]
The California Transparency in Supply Chains Act of 2010 (SB 657) requires companies operating in California to disclose their efforts to eradicate slavery and human trafficking from their direct supply chains. KnowTheChain.org has examined this company's disclosure statement and concluded that it addresses the majority of SB 657 requirements. Follow the link to see this company's disclosure statement.
[Source 2013][More on Workers Rights]
As You Sow's 2018 report, Mining the Disclosures, is a deep analysis of 206 companies' human rights performance in relation to sourcing conflict minerals from the Democratic Republic of the Congo (DRC). This company's score was above 50% (Adequate).
[Source 2018][More on Human Rights]
OpenSecrets.org tracks the influence of money on U.S. politics, and how that money affects policy and citizens' lives. Follow link to see this company's record of political donations, lobbying, outside spending and more.
|Company Structure||Public company|
|Revenue||US$22 billion in 2013|
|# Employees||69,000 in 2013|
|Subsidiaries||Abbott Australasia Pty Ltd|
|Address||Chicago, Illinois, USA|